We are excited to share with you that Dr. Peter Schultz, CEO of The Scripps Research Institute, visited our headquarters on October 17 and gave an inspiring public lecture. Dr. Schultz is the CEO of The Scripps Research Institute and the Founder and Director of California Institute for Biomedical Research. He is also a member of the US National Academy of Sciences and the Institute of Medicine of the National Academy of Sciences.
Dr. Schultz’s research is at the interface of chemistry and biology. By developing technologies to make and characterize molecules and materials hundreds to million at a time, his work has dramatically impacted our ability to make create molecules with novel biological and physical properties-ranging from medicines to materials. He has pioneered the development of new drugs that affect endogenous stem cells for neurodegenerative diseases and diseases of aging, and has led efforts that have resulted in new therapies for the treatment of multiple sclerosis, lung and blood cancers, and malaria. Professor Schultz is a founder of nine biotech/tech companies that have pioneered the application of molecular diversity technologies to challenge in energy, materials and human health.
Dr. Schultz’s passion for science and accomplishments are impacting both academia and industry in significant ways, and continues to inspire our 9,000 scientists, many of whom with learning and research experience from leading organizations like The Scripps Research Institute, in their pursuit of scientific excellence and innovative solutions for our partners and patients.